SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-047549
Filing Date
2014-08-07
Accepted
2014-08-07 08:45:33
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v384513_10q.htm 10-Q 427869
2 EXHIBIT 31.1 v384513_ex31-1.htm EX-31.1 10374
3 EXHIBIT 31.2 v384513_ex31-2.htm EX-31.2 9955
4 EXHIBIT 32.1 v384513_ex32-1.htm EX-32.1 5991
  Complete submission text file 0001144204-14-047549.txt   4506289

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20140630.xml EX-101.INS 677761
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20140630.xsd EX-101.SCH 42316
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20140630_cal.xml EX-101.CAL 42621
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20140630_def.xml EX-101.DEF 237588
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20140630_lab.xml EX-101.LAB 285194
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20140630_pre.xml EX-101.PRE 277641
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 141021901
SIC: 2834 Pharmaceutical Preparations